Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain endothelial cells orchestrate a neuroprotective antiviral state in the CNS in response to peripheral viral pattern sensing.

Immunity·2026
Same author

Early insights into donor-derived cell-free DNA in a preclinical model of face vascularized composite allotransplantation.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Loss of <i>Sun2</i> ablates nuclear mechanosensing-driven extracellular matrix production and mitigates lung fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

SUN2 mediates epigenetic remodeling to drive mechanotransduction during skin fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Distinctive DNA sequence features define epigenetic longevity of inflammatory memory.

Science (New York, N.Y.)·2026
Same author

Decoding keloids: Single-cell heterogeneity, emerging role of adipocytes, molecular biomarkers, and therapeutic implications in skin of color.

The Journal of investigative dermatology·2026
Same journal

Effect of network topology on neuronal encoding based on spatiotemporal patterns of spikes.

HFSP journal·2010
Same journal

From genes to neural tube defects (NTDs): insights from multiscale computational modeling.

HFSP journal·2010
Same journal

Cytoskeletal dynamics in fission yeast: a review of models for polarization and division.

HFSP journal·2010
Same journal

Biocrystallography: past, present, future.

HFSP journal·2010
Same journal

Robustness versus evolvability: a paradigm revisited.

HFSP journal·2010
Same journal

Molecular motors as an auto-oscillator.

HFSP journal·2010
See all related articles

Related Experiment Video

Updated: Jun 23, 2026

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

Reprogramming somatic cells to their embryonic state.

Valerie Horsley1, Elaine Fuchs

  • 1Laboratory of Mammalian Cell Biology and Development, Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10021.

HFSP Journal
|May 1, 2009
PubMed
Summary
This summary is machine-generated.

Scientists reprogram somatic cells into pluripotent stem cells using four factors. This breakthrough offers an alternative to embryonic stem cells for regenerative medicine, advancing treatments for diseases like Parkinson's and diabetes.

More Related Videos

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

Related Experiment Videos

Last Updated: Jun 23, 2026

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Epigenetics

Background:

  • Embryonic stem (ES) cells are pluripotent, capable of forming all adult cell types.
  • ES cells hold promise for treating diseases like Parkinson's and diabetes.
  • Ethical concerns regarding human embryo use limit ES cell research and therapy development.

Purpose of the Study:

  • To identify mechanisms maintaining pluripotency and differentiation in ES cells.
  • To explore alternative methods for generating pluripotent cells without using embryos.
  • To advance regenerative medicine therapies.

Main Methods:

  • Reprogramming somatic cells into induced pluripotent stem cells (iPSCs).
  • Utilizing the expression of four specific transcription factors.
  • Analyzing the resulting iPSCs for pluripotency and differentiation potential.

Main Results:

  • Novel methods successfully reprogrammed somatic cells into ES-like cells.
  • The process involved the expression of only four transcription factors.
  • These reprogrammed cells exhibit pluripotent potential, similar to ES cells.

Conclusions:

  • New methods provide a way to generate pluripotent cells without using embryos.
  • These findings illuminate mechanisms of pluripotency.
  • Reprogrammed cells offer a promising model for advancing regenerative medicine therapies.